← Back to EIKN

Eikon Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026
−$88−$83−$105−$68
−$1.63−$2.46−$36.94−$26.91
54342.82.8

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.